CLINICAL_TRIALS
trial_result
· 2025-03-21
Clinical Trial Update: Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS) [Phase 2]
Summary
A Phase 2 study of SAR443820 in amyotrophic lateral sclerosis was terminated, and the trial results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: TERMINATED | Results posted: 2025-03-21